What is the emergency room management for a patient who overdosed on psilocybin (magic mushrooms)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Room Management of Psilocybin (Magic Mushroom) Overdose

The emergency room management of psilocybin (magic mushroom) overdose should focus on supportive care, as there is no specific antidote for psilocybin toxicity, with monitoring of vital signs and management of psychological symptoms being the cornerstones of treatment.

Initial Assessment and Stabilization

  • Assess airway, breathing, and circulation
  • Obtain vital signs including temperature (hyperthermia may occur)
  • Perform focused neurological examination
  • Check for signs of the psilocybin toxidrome:
    • Visual and auditory hallucinations
    • Altered mental status
    • Mydriasis (dilated pupils)
    • Tachycardia
    • Hypertension
    • Nausea and vomiting
    • Diaphoresis (excessive sweating)

Management Approach

Supportive Care

  • Provide a calm, quiet environment with minimal stimulation to reduce anxiety and agitation
  • Monitor vital signs continuously
  • Provide IV fluids if needed for dehydration
  • Treat hyperthermia if present with cooling measures

Psychological Support

  • Reassurance and verbal de-escalation for agitated patients
  • Avoid physical restraints if possible as they may worsen psychological distress
  • Consider psychiatric consultation for severe psychological reactions

Pharmacological Interventions

  • For severe agitation or anxiety:
    • Benzodiazepines are first-line therapy
    • Consider lorazepam 1-2 mg IV/IM or diazepam 5-10 mg IV/IM
    • Titrate to effect for symptom control

Gastrointestinal Decontamination

  • Activated charcoal (1 g/kg orally) may be considered if presentation is within 1-2 hours of ingestion 1
  • Not recommended if:
    • Patient has altered mental status without airway protection
    • Presentation is delayed (>2 hours after ingestion)

Special Considerations

Polysubstance Ingestion

  • Consider the possibility of co-ingestion with other substances
  • Obtain toxicology screening if available, but don't delay treatment waiting for results

Complications Management

  • For persistent vomiting: antiemetics (ondansetron 4-8 mg IV)
  • For severe myalgias: supportive care and hydration 2
  • For rare cases of methemoglobinemia: consider methylene blue if symptomatic and levels >30% 2

Disposition

  • Most patients can be discharged after 6-8 hours of observation if symptoms are resolving 3

  • Criteria for discharge:

    • Resolution of hallucinations and altered mental status
    • Stable vital signs
    • Ability to tolerate oral intake
    • Safe discharge plan
  • Consider admission for:

    • Persistent severe symptoms
    • Significant psychiatric symptoms
    • Evidence of rhabdomyolysis or other complications
    • Suspected co-ingestion of other substances

Pitfalls and Caveats

  • Psilocybin toxicity can be difficult to diagnose as standard urine drug screens do not detect psilocybin 4
  • Symptoms typically resolve within 6 hours but may last up to 12 hours in some cases 3
  • Unlike Amanita phalloides mushrooms, psilocybin mushrooms do not cause hepatotoxicity, so penicillin G and silymarin treatments are not indicated 1
  • Avoid administering haloperidol or other typical antipsychotics as first-line agents as they may lower seizure threshold and worsen outcomes

Remember that while psilocybin mushroom ingestion can cause significant psychological distress, it rarely causes life-threatening physical symptoms when ingested alone. The focus should be on supportive care and management of psychological symptoms until the effects naturally subside.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous mushroom poisoning.

Annals of emergency medicine, 1985

Research

Unrecognized magic mushroom abuse in a 28-year-old man.

The American journal of emergency medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.